Amy C Rowat - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Amy C Rowat

Showing results (61-70 of 66) with videos related to

Pageof 7

Sort By:

You have reached the last page of results.This site can display upto 66 results.

Cancer Research|August 30, 2018

Emerin Deregulation Links Nuclear Shape Instability to Metastatic PotentialMariana Reis-Sobreiro, Jie-Fu Chen, Tatiana Novitskaya, et al.

Cancer|April 24, 2019

Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumorsPreethi H Gunaratne, Yinghong Pan, Abhi K Rao, et al.

Cell Reports|December 12, 2019

A Study of High-Grade Serous Ovarian Cancer Origins Implicates the SOX18 Transcription Factor in Tumor DevelopmentKate Lawrenson, Marcos A S Fonseca, Annie Y Liu, et al.

Cell|July 5, 2020

Type V Collagen in Scar Tissue Regulates the Size of Scar after Heart InjuryTomohiro Yokota, Jackie McCourt, Feiyang Ma, et al.

Oncotarget|April 2, 2016

miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancerYinghong Pan, Gordon Robertson, Lykke Pedersen, et al.

Oncotarget|April 14, 2017

Correction: miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancerYinghong Pan, Gordon Robertson, Lykke Pedersen, et al.

Pageof 7

Search research articles

Showing results (61-70 of 66) with videos related to

Sort By:

Pageof 7

You have reached the last page of results.This site can display upto 66 results.

Cancer Research|August 30, 2018

Emerin Deregulation Links Nuclear Shape Instability to Metastatic PotentialMariana Reis-Sobreiro, Jie-Fu Chen, Tatiana Novitskaya, et al.

Cancer|April 24, 2019

Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumorsPreethi H Gunaratne, Yinghong Pan, Abhi K Rao, et al.

Cell Reports|December 12, 2019

A Study of High-Grade Serous Ovarian Cancer Origins Implicates the SOX18 Transcription Factor in Tumor DevelopmentKate Lawrenson, Marcos A S Fonseca, Annie Y Liu, et al.

Cell|July 5, 2020

Type V Collagen in Scar Tissue Regulates the Size of Scar after Heart InjuryTomohiro Yokota, Jackie McCourt, Feiyang Ma, et al.

Oncotarget|April 2, 2016

miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancerYinghong Pan, Gordon Robertson, Lykke Pedersen, et al.

Oncotarget|April 14, 2017

Correction: miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancerYinghong Pan, Gordon Robertson, Lykke Pedersen, et al.

Pageof 7